Concord Drugs Ltd share price logo

Concord Drugs Ltd Share Price

BSE: 538965

Small Cap

Healthcare Sector

₹75.51

-1.79

(-2.32%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Concord Drugs Ltd Stock Performance

as on December 5, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹75.15
    ₹77.99
    downward going graph

    0.48%

    Downside

    3.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹26.1
    ₹92.52
    downward going graph

    65.44%

    Downside

    22.53%

    Upside

    downward going graph

Concord Drugs Ltd share price movements today

Previous Close
₹77.30
Open
₹77.99
Volume
861.00
Upper Circuit
₹81.16
Lower Circuit
₹73.44
Day's Low - High
₹75.15 - ₹77.99
52 Week Low - High
₹26.1 - ₹92.52

Concord Drugs Ltd Historical Returns

1 Month Return
+ 1.78 %
3 Month Return
+ 14.39 %
1 Year Return
+ 99.42 %
3 Year Return
+ 128.79 %
5 Year Return
+ 218.57 %

Concord Drugs Ltd Fundamentals

as on December 5, 2025 at 4:01 pm IST

Market Cap

₹75.50 Cr

Return on Equity (ROE)

0.88

PE Ratio (TTM)

130.17

Return on capital employed (ROCE)

4.49

Industry PE ratio

42.28

Beta (LTM)

0.38

P/B Ratio

0.91

Dividend Yield

0

PEG Ratio

119.42

Quarterly Earnings Growth YOY

375

EPS (TTM)

0.34

Sector

Pharmaceuticals

Book Value

34.11

Technical Analysis

Bullish

View Technical Analysis

Concord Drugs Ltd Stock Valuation

as on December 5, 2025 at 4:01 pm IST

Concord Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Industry (42.28x)

December 5, 2025

Today (130.17x)

December 5, 2025

Highest (791.40x)

July 3, 2024

LowHigh

Today’s Price to Earnings Ratio: 130.17x

Concord Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Concord Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Concord Drugs Ltd image
Concord Drugs Ltd
NA75.5043.71%0.70145
Oxygenta Pharmaceutical Ltd image
Oxygenta Pharmaceutical Ltd
NA218.39103.41%0.00-10109
Hikal Ltd image
Hikal Ltd
BUY2,997.937.8%0.70901,859
Granules India Ltd image
Granules India Ltd
BUY13,610.088.51%0.645014,481
Cian Healthcare Ltd image
Cian Healthcare Ltd
NA13.77-12.07%0.82-2630
See all

Concord Drugs Ltd Stock’s Investor Sentiment and Interest

Search interest for Concord Drugs Ltd Stock has increased by 94% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:94% versus previous 30 day period

Concord Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
13.53
12.31
8.98
7.52
12.78
15.64
11.69
12.36
10.8
10.39
13.61
10.28
Total Income
13.53
12.31
8.98
7.52
12.78
15.64
11.69
12.37
10.8
10.4
13.61
10.28
Expenses
12.08
11.34
7.52
5.91
12.15
15.29
10.86
11.49
9.41
9.35
12.59
9.18
Operating Profit
1.45
0.97
1.46
1.61
0.63
0.35
0.83
0.87
1.39
1.04
1.02
1.1
Operating Profit Margin %
10.72%
7.88%
16.26%
21.41%
4.93%
2.24%
7.1%
7.04%
12.87%
10.01%
7.49%
10.7%
Profit Before Interest, Tax and Depreciation
1.44
0.97
1.46
1.61
0.63
0.35
0.83
0.88
1.39
1.05
1.02
1.1
Interest
0.45
0.5
0.44
0.43
0.5
0.5
0.45
0.47
0.5
0.61
0.49
0.49
Depreciation
0.38
0.33
0.38
0.39
0.39
0.39
0.34
0.34
0.37
0.38
0.37
0.34
Profit Before Tax
0.61
0.14
0.64
0.79
-0.26
-0.54
0.04
0.07
0.52
0.06
0.16
0.27
Tax Paid
0.16
-0.03
0.15
0.24
-0.01
-0.21
0.02
0.03
0.31
0.02
0.04
0.08
Profit After Tax
0.45
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Total Net profit including share of profit / Loss from associate company
0.45
0.16
0.49
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
EPS
0.52
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Actual EPS
0.52
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Adjusted EPS
0.52
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
Diluted EPS
0.52
0.17
0.53
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19

Concord Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
58.96
52.08
44.92
45.24
Total Income
59.06
52.09
44.93
45.26
Expenses
53.36
47.51
40.88
41.11
Operating Profit
5.6
4.57
4.04
4.13
Operating Profit Margin %
9.5%
8.77%
8.99%
9.13%
Profit Before Interest, Tax and Depreciation
5.69
4.58
4.05
4.15
Interest
1.68
1.71
1.87
2.03
Depreciation
1.76
1.63
1.56
1.43
Profit Before Tax
2.25
1.24
0.62
0.69
Tax Paid
0.65
0.26
0.16
0.35
Profit After Tax
1.59
0.99
0.47
0.34
Total Net profit including share of profit / Loss from associate company
1.59
0.99
0.47
0.34
EPS
1.82
1.06
0.47
0.34
Actual EPS
1.82
1.06
0.47
0.34
Adjusted EPS
1.82
1.06
0.47
0.34
Diluted EPS
1.82
1.06
0.47
0.34

Concord Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.77
1.66
0.79
3.72
Cash Flow from Investing Activities
0.01
-1.41
0.01
0.01
Cash Flow from Financing Activities
1.68
0.62
0.27
-1.43
Net Cash Flow
0.01
0.02
0.07
-0.02

Concord Drugs Ltd Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
52.13%
52.13%
52.13%
55.41%
55.41%
55.41%
55.41%
54.39%
54.39%
54.39%
54.39%
54.39%
Public
47.87%
47.87%
47.87%
44.59%
44.59%
44.59%
44.59%
45.61%
45.61%
45.61%
45.61%
45.61%
Total Outstanding Shares
93,15,470
93,15,470
93,15,470
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
Total Shareholders
3,204
3,198
3,957
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718

Concord Drugs Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Concord Drugs Ltd.

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit jumped 375% since last year same period to ₹0.19Cr in the Q2 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 58.33% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, Concord Drugs stock has moved up by 137.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.04 Cr → 0.19 Cr (in ₹), with an average increase of 51.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Concord Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 45.61% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.39% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 134.4% return, outperforming this stock by 5.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 13.61 Cr → 10.28 Cr (in ₹), with an average decrease of 24.5% per quarter

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Revenue: ₹10.28Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.19Cr as on September 2025 (Q2 FY26)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
IndustryPharmaceuticals
CEOS Nagi Reddy
E-voting on sharesClick here to vote

FAQs

What is Concord Drugs Ltd share price today?

Concord Drugs Ltd share price today stands at ₹75.51 as on at the close of the market. Concord Drugs Ltd share today touched a day high of ₹77.99 and a low of ₹75.15.

What is the 52 week high and 52 week low range for Concord Drugs Ltd share?

Concord Drugs Ltd touched a 52 week high of ₹92.52 and a 52 week low of ₹26.1. Concord Drugs Ltd share price today i.e. is closed at ₹75.51, which is -18.39% down from its 52 week high and 189.31% up from its 52 week low.

What is Concord Drugs Ltd's market capitalisation today?

Concord Drugs Ltd market capitalisation is ₹75.50 Cr as on .

How to buy Concord Drugs Ltd shares?

To buy Concord Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538965 or Concord Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Concord Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Concord Drugs Ltd trading volume today?

Concord Drugs Ltd trading volume is 861.00 as on . This means that 861.00 shares of Concord Drugs Ltd were bought and sold on the stock market during today's trading session.